Click here to access this webinar on demand.
Join us for a CLE that will provide an overview of US FDA authorities and regulatory programs applied to cannabis-derived products. The discussion will focus on cannabis in drug development and FDA guidance and resources for cannabis research to support health claims for marketing cannabis-derived products.
*This CLE program is not intended to provide legal advice or establish attorney-client relationships regarding cannabis.
Speaker:
- Heather Hatcher, Ph.D., Regulatory Scientist, Womble Bond Dickinson